Clinical Trial Update: Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1 [Phase 1]

View source ↗

Summary

A Phase 1 safety and pharmacokinetics study evaluating the antibodies PGT121.414.LS alone and with VRC07-523LS in infants exposed to HIV-1. The trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PGT121.414.LS
• VRC07-523LS

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV-1 | Phase 1 | Status: RECRUITING